Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GT Biopharma, Inc. - Common Stock (NQ:GTBP)

6.800 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 6.800
Bid (Size) 4.000 (100)
Ask (Size) 7.410 (100)
Prev. Close 6.800
Today's Range 6.800 - 6.800
52wk Range 0.2221 - 11.98
Shares Outstanding 31,553,892
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Top movers in Friday's session ↗
Via Chartmill

Performance

YTD
+732.2%
+732.2%
1 Month
+2277.6%
+2277.6%
3 Month
+1445.5%
+1445.5%
6 Month
+1541.3%
+1541.3%
1 Year
+1072.4%
+1072.4%

More News

Read More
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell
From Equity Insider
Via GlobeNewswire
News headline image
Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
From Biotech Insider
Via GlobeNewswire
These stocks are moving in today's session ↗
Via Chartmill
What's going on in today's session ↗
Via Chartmill
News headline image
"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies
From World Street Intelligence
Via GlobeNewswire
Which stocks are gapping on Thursday? ↗
Via Chartmill
News headline image
A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology
From USA News Group
Via GlobeNewswire
News headline image
Solid Tumor Treatment Race Heats Up as Multi-Billion-Dollar Oncology Market Enters High-Growth Phase
Via FinancialNewsMedia
Discover the top movers in Thursday's pre-market session. ↗
Via Chartmill
News headline image
Replays from RedChip's Biotech Investor Conference Now Available
Via ACCESS Newswire
News headline image
RedChip's April 16 Virtual Investor Conference to Highlight Companies Driving the Next Wave of Biotech Innovation
Via ACCESS Newswire
Monday's session: top gainers and losers ↗
Via Chartmill
News headline image
THE SCARCITY DOCTRINE: 5 Assets Securing the 2026 Material Cycle
From Equity Insider
Via GlobeNewswire
News headline image
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
From Equity Insider
Via GlobeNewswire
News headline image
THE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis
From USA News Group
Via GlobeNewswire
News headline image
THE REALITY CHECK: 5 Assets Delivering Proof in a Speculative Market
From Equity Insider
Via GlobeNewswire
News headline image
GT Biopharma, Inc. (NASDAQ:GTBP) Offers Near-Term Catalyst Opportunity with Advancing Phase 1 Trials
Via ACCESS Newswire
News headline image
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Via Benzinga
News headline image
The market is filled with gapping stocks in Monday's session. ↗
Via Chartmill
News headline image
These stocks are moving in today's pre-market session ↗
Via Chartmill

Frequently Asked Questions

Is GT Biopharma, Inc. - Common Stock publicly traded?
Yes, GT Biopharma, Inc. - Common Stock is publicly traded.
What exchange does GT Biopharma, Inc. - Common Stock trade on?
GT Biopharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for GT Biopharma, Inc. - Common Stock?
The ticker symbol for GT Biopharma, Inc. - Common Stock is GTBP on the Nasdaq Stock Market
What is the current price of GT Biopharma, Inc. - Common Stock?
The current price of GT Biopharma, Inc. - Common Stock is 6.800
When was GT Biopharma, Inc. - Common Stock last traded?
The last trade of GT Biopharma, Inc. - Common Stock was at 09/28/26 04:00 PM ET
What is the market capitalization of GT Biopharma, Inc. - Common Stock?
The market capitalization of GT Biopharma, Inc. - Common Stock is 214.57M
How many shares of GT Biopharma, Inc. - Common Stock are outstanding?
GT Biopharma, Inc. - Common Stock has 215M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.